German drugs and chemicals company Merck KGaA is mulling a sale of its generic drug business, which could be worth about €4-billion ($5.3-billion U.S.), business daily Handelsblatt reported ...

The United States Food and Drug Administration (FDA) has stopped the sale of copycat versions of Ozempic and Wegovy, the Type 2 diabetes drugs used for weight loss. In 2022, the FDA announced there ...

India News: NEW DELHI: Sale of generic versions of cancer medication Ibrutinib, used to treat leukaemia, has been blocked across the country, denying patients acc.

In December, Teva Pharmaceuticals, the world leader in generic drugs, announced a major restructuring that included plans to lay off 26 per cent of its work force, or 14,000 people.

Consumer self-care products company Perrigo Company plc (PRGO) recently announced that it has completed the sale of its Generic Rx Pharmaceuticals business. The company has sold the business to ...

The sale process for Mallinckrodt's generic drug business comes amid a wave of dealmaking in the sector. Last month, Fresenius SE & Co KGaA (FREG.DE) agreed to acquire generic drugmaker Akorn Inc ...

FDA stops sale of generic versions of Ozempic and Wegovy: What it means for patients - The compounded versions of the drug were originally sold to combat a brand-name shortage ...

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper. Americans shelled out an estimated $71 billion for weight-loss drugs in ...

In 2022, the FDA announced there was a shortage of the brand-name medications, which allowed compounding pharmacies to make generic semaglutide, the main active ingredient in the weight-loss drugs.